WO2000017800A9 - Reducing risk using behavioral and financial rewards - Google Patents
Reducing risk using behavioral and financial rewardsInfo
- Publication number
- WO2000017800A9 WO2000017800A9 PCT/US1999/022020 US9922020W WO0017800A9 WO 2000017800 A9 WO2000017800 A9 WO 2000017800A9 US 9922020 W US9922020 W US 9922020W WO 0017800 A9 WO0017800 A9 WO 0017800A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- msured
- risk
- component
- insured
- medical
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q40/00—Finance; Insurance; Tax strategies; Processing of corporate or income taxes
- G06Q40/08—Insurance
Definitions
- Certain kinds of insurance also have a substantial effect on the family of the insured person
- the insured person is often faced with the dilemma of either ( 1) reduction to penury to quality for government support, or (2) spending their entire estate on long-term care
- the family of the insured person also has interests against these options
- Modeling and Scoring Risk Assessment assigned to the same assignee docket number HHN-003 describes techniques for modeling and scoring risk assessment that are time-dependent, and in one embodiment are responsive to progression of a disease or degenerate e condition in a patient
- One aspect of this co-pending application is that the insurer can dvnamicalh adjust the risk assessment of individual insured persons in response to action taken (or not taken) those insured persons to maintain their own health
- the underwriter can thus dynamically adjust the cost or the benefits of the insurance policy in response to those actions By doing so.
- the underwriter, the insured person, and the insured person s family have the common goal of maximizing the useful life and independence of the insured person
- dynamic reassessment can be performed in conjunction with a monitoring and scoring system for determining risk assessment for populations and for individuals ith regard to those populations It would also be desirable for the insured person (and associated others) to make use of dynamic risk are assessment to monitor and influence the behavior of the insured person, to reduce the risk It would also be desirable to provide the insured person, and the insured person ' s family with information available to the underwriter, and to suggest particular prescribed or proscribed actions that would reduce short- term risk and provide a greater payoff for all concerned
- the insured person, and associated others with feedback information from dynamic reassessment of the risk associated w ith the insured person, so that the insured person, and associated others. can act to minimize that risk
- This advantage is achieved in an embodiment of the invention in which the insured person and their beneficiaries are provided with feedback information and instruction responsive to dynamic risk reassessment, and in which payments form an associated set of insurance products are allocated dependant on compliance with that feedback
- one such insurance product includes a long-term care component and a life insurance component, and devotes a fraction of the product premium to one or the other component in response to compliance with the feedback offered by the underwriter
- the invention provides a set of techniques and products in which one or more insured persons and one or more associated beneficiaries are monitored with regard to risk reassessment, are g ⁇ en feedback information responsive to that dynamic risk reassessment, and are encouraged to comply with the feedback information
- the insured persons and associated beneficiaries are coupled to a client-server s ⁇ stem that is configured to obtain dynamic measurement of medical information (for example, using bio-medical devices or using a question and answer format), and the client-server system is configured to alert the insured persons and associated beneficiaries to suggested behaviors for reducing risk
- the preferred embodiment includes an insurance product in which portions of the insurance premium are allocated to one or more components (such as a long-term care benefit or a life insurance benefit), in response to compliance with the suggested behaviors
- the insured is provided with an incentive for compliance with the suggested behaviors for reducing risk by receiving a more beneficial allocation of the premium to the components of the insurance product
- an insured patient is examined at intervals by medical personnel, to determine medical information that can be used as factors for dynamically determining a risk assessment for that insured patient
- the medical personnel can determine a medical regimen (possibly including diet, exercise, prescribed medication, or other factors) that are intended to reduce the insured- against risk
- the insured patient and where appropriate, associated beneficiaries or other close relations, use a client device with a client-server system to provide dynamic medical information regarding the condition of the insured
- the client deuce can periodically measure blood glucose, blood pressure, heart rate, weight, and the like Similctrly the client device can periodically question the insured patient or the close relations for information about the insured, such as affect or mutation, diet or exercise, and the like
- a server device receiving that information from the client device can dynamicalh reassess risk factors associated with the insured patient, and can alert medical personnel or close relations in response thereto
- the se ⁇ er deuce can modify which portions of an insurance premium (or
- FIGURE 1A shows a diagram of a system for data collection and interpretation for a population.
- FIGURE IB shows details of the client device shown in Fig. 1A.
- FIGURE 1C shows devices that may be connected to client device.
- FIGURE ID shows details of the data review device.
- FIGURE 2 illustrates a data flow diagram indicating some of the data paths used in a preferred embodiment.
- FIGURE 3A illustrates a process for determining dynamic risk assessment.
- FIGURE 3B illustrates a process used to evaluate patient information.
- FIGURE 4 illustrates a process used to respond to risk
- FIGURE 5 illustrates a process used to determine feedback information
- Embodiments of the invention can be implemented using general-purpose processors or special purpose processors operating under program control, or other circuits, adapted to particular process steps and data structures described herein
- Other embodiments include computer program products that contain computer code embodied m a computer readable media for causing a computer to perform the process steps Implementation of the process steps and data structures described herein would not require undue experimentation or further invention
- the invention enables dynamic risk determination of an insured ' s condition
- An example of when the invention can be used is if the insured has a progressive condition. whichwiU eventually require long-term care (such as diabetes), but for which in-home care is currently appropriate
- Another example where dynamic risk determination can be used is if the insured is at risk for a medical setback (such as an
- MI MI or a stroke
- the underwriter allows the underwriter to dynamically determine the current risk to the insured and to provide incentives to the insured to reduce that risk
- Fig. 1A shows a block diabram of a system for data collection and interpretation for a population
- a system 100 includes a client device 110.
- a server device 120 including a database of information 121 and a program memory 122. and a data review element 130 These devices are connected via a communication channel 140.
- a communication channel 140 such as a communication network as is well known in the art. and as more fully described in the Phenoscope and Phenobase patent application (serial no 90/041.809)
- the communication channel 140 may be a simple point-to-point network (for example a wire connecting the client device 110 with the server device 120). or a complex network such as the Internet
- the client device 110 is disposed locally to a patient 111 (the insured), and includes an output element 112 for presenting information to the patient 111. and an input element 113 for entering information from the patient 111
- “locally” refers to a logical relationship to the patient 111. and does not have any necessary implication with regard to actual physical position
- the client device 110 is relat ⁇ ely small or compact, and can be disposed on a night table or otherwise near the patient 111
- the output element 112 includes a display screen 114. on which questions and suggested answers can be displayed for the patient 111. to facilitate information entry, or on which instructions can be displayed for the patient 111. to instruct the patient 111
- the output element 112 can also include a speaker 115. to present information in conjunction with or in alternative to the d ⁇ spla ⁇ screen 114
- the output element 112 can also include a bell or other sound element, or a bright light 119 or a flag, to alert the patient 111 that the client device 110 has questions or information for the patient 111
- the input element 113 includes a plurality of buttons 116A-D for entering information
- the input element 113 can also include one or more data ports 117A-D for entering information from other devices Referring to Fig. 1C.
- such other devices 118 can include a medical measurement device, such as a blood glucose meter or a blood pressure monitor
- Such other devices 118 can also include a general purpose or special purpose client workstation, such as a personal computer or a hand-held digital calendar
- the serv er device 120 is disposed logically remotely from the patient 111. and includes a database 121 of information about the patient 111 and about other patients in a related population thereof As used herein "remotely " ' refers to a logical relationship to the patient 111. and does not have any necessary implication with regard to actual physical position
- the database 121 includes medical history, medical regimen, and risk progression information for the insured and a similarly situated population
- the database 121 also includes the compliance background for the insured indicating how well the insured follows the prescribed medical regimen and avoids the proscribed activities
- the server device 120 also includes the program memor 122 that contains program code and data to cause the server device 120 to perform subsequenth described processes
- the server 120 and database 121 are preferably accessible using a standard network connection (such as a world wide web connection)
- the server 120 and database 121 may include single stand-alone computers or multiple computers distributed throughout a network
- the data review element 130 is disposed logically remoteh from the patient
- the operator 132 can comprise medical personnel, a deuce operated by medical personnel, or a similar deuce, capable of interacting with the interface 131 to receive information from the data reuew element 130 and possibh to enter information into the data reuew element 130
- Inlormation entered into the data reuew element 130 can be entered for ultimate transmission to the server device 120 or to the client deuce 110
- the date reuew element 130 is preferably a personal computer remote terminal, web TV unit. Palm Pilot unit, interactiv e voice response s stera or am other communication technique
- the data review element 130 functions as a remote interface for entering serv er 120 or client device 110 messages and queries to be communicated to the individuals
- the data review element 130 also functions to provide the professional to ev coe the progression of the insured and to monitor the rnsured ' s medical regimen Other and further information regarding the system 100 is shown in
- Fig. 2 illustrates a data flow diagram, indicated by general reference character 200. that indicates how data flows within a preferred embodiment
- the nodes include an insured 201. a client device 203. a server device 205. an accounting server 207. a workstation 209. and a professional 211
- These nodes are connected by data flows that include an 'insured-chent device " data stream 221. a client device-insured data stream 223. a client-server data stream 225. a server-client data stream 227. a server- workstation data stream 229. a workstation-server data stream 231. a workstation- professional data stream 233. a professional-workstation data stream 235. a 'workstation- accounting server " data stream 237.
- Each of these data streams transfer data between the nodes connected by the data stream
- the server device sends patient protocol and interrogatories to the insured by sending this information across the server-client data stream 227 to the client device 203
- the client device 203 then instructs or queries the insured 201 utilizing the client device-insured data stream 223
- the insured 201 responds to the queries, instructions, or through bio-medical input devices to the client device 203 using the "insured-chent dev ice " data stream 221
- the client dev ice 203 passes this acquired information to the server device 205 over the client-sen er data stream 225
- the server device 205 stores the information acquired from the insured 201
- Feedback is provided to the insured 201 by sending feedback information from the sen er device 205 to the client device 203
- This feedback information can include additional medical regimens for the insured 201 to timelv follow (for example, additional tests that are determined bv the server dev ice 205 responsiv e to the information just gathered from the insured)
- the professional 211 uses the workstation 209 (passing data ov er both the workstation-pro fess ⁇ on ⁇ al data stream 233 and the professional-workstation data stream 235) to access and/or modify data received by. stored on or created on the server device 205 This data is access using the sen'er-workstation data stream 229
- the professional 211 can also modify the medical regimen for the insured or provide other information for the insured These modifications are sent to the server device 205 over the workstation-server data stream 231 and then to the insured using the ever-chent data stream 227. the client device 203. and the client device-insured data stream 223 The professional 211.
- using the workstation 209 can send information (reflecting benefits to the insured) to the accounting server 207 using the ' workstation- accounting server ' data stream 237
- the status of benefits can be sent directly to the insured using the 'accounting server-insured ' data stream 239 (for example by using postal mail. FAX or other traditional mechanism) or the information can be sent over the " accounting server-server device' data stream 241 to the server device 205 and on to the insured sing previously discussed paths
- the professional 211 assesses the insured-against risk using both the static data most recently collected from the insured, the progression over time of the data collected from the insured and information known to. or accessible by the professional 211 this assessment includes the insured ' s compliance with the prescribed medical regimens and other environmental and behavioral factors This assessment can also include information and recommendations provided by artificial intelligence expert sv stems that are accessible to the professional 211 through the workstation 209
- Fig. 3A illustrates a dynamic risk assessment process, indicated by general reference character 300.
- the dynamic risk assessment process 300 is cyclic in normal circumstances
- a 'gather patient information " step 301 obtains medical information (such as bio-medical information) from the insured (using the client device 1 10) by using a series of questions or by using bio-medical sensors
- the medical information is gathered according to a protocol provided by the server device 120
- This medical information is sent to a server device that performs an " evaluate patient information step 303 that determines one or more risk factors for the insured as is subsequently described with respect to Fig.
- the dvnamic risk assessment process 300 delays for an appropriate time at a delay step 305
- This delay can be varied as appropriate for the insured, the msured ' s condition, the caregivers. and the insurance provider
- the delay step 305 determines the time interval between gathering information from the insured and is appropriately set to be (for example and without limitation) some number of days, weeks or months Eventually, the delay ends at a " delay complete' step 307 and the dynamic risk assessment process 300 repeats at the 'gather patient information ' step 301 to re-determine the insured-against risk for the insured
- the medical information gathered by the ' gather patient information " step 301 is specific to the msured's current risk and progression of the condition
- the insured or caregiver may be periodically instructed to check for sores on extremities if the msured is diabetic
- the caregiver can provide mformation about affect or mentation If the insured interacts with the client device 110.
- the response time to questions can also be gathered
- the 'gather patient mformation ' step 301 and the evaluate patient mformation step 303 can be repeated dependent on the data acquired from the msured by the previous iteration
- the server device 120 can send the client device 110 a protocol to cause the client device 110 to obtam the new mformation from the msured. caregiver. or other person
- Fig. 2B illustrates an 'evaluate patient information " process, mdicated by general reference character 320 that reassesses the risk based on the gathered mformation and responds to that risk
- the "evaluate patient mformation ' process 320 is mv oked by the evaluate patient mformation " step 303 of Fig. 3A and initiates at a "start " terminal 321
- the 'evaluate patient mformation " process 320 continues to a 'send data to server device ' procedure 323. performed by the client device 110.
- the medical mformation is stored on the database 121 by a 'store data' procedure 325
- a 'reassess risk ' procedure 327 (as disclosed in Application Serial No . attorney docket number HHN-003) can use the medical mformation.
- the risk m cludes one or more risk factors These risk factors are used to determine an msured-agamst risk
- Example risk factors include information such as patient smokes patient has diabetes. " "patient has diabetes and doesn t bother to check his blood sugar regularlv . " etc
- the ' evaluate patient mformation " process 320 continues to a respond to risk " procedure 329 (subsequently descnbed with respect to Fig. 4)
- the 'respond to risk ' procedure 329 determines one or more medical regimens for the msured These medical regimens are selected to reduce the risk factors and thus to reduce the msured-agamst risk of the msured
- the 'respond to risk ' procedure 329 can also adjust the proportion of the insurance cost allocated to components of the financial product used by the msured
- the 'reassess risk " procedure 327 and the 'respond to risk ' procedure 329 need not be performed every time data is received by the server device 120 These procedures can be executed mdependent of the following procedures
- the dynamic risk assessment process 300 can also contmue to a 'determme feedback mformation " procedure 331 that develops feedback for the msured that can include one or more medical regimens, display of bio-medical mformation. encouragement to follow the suggested medical regimen or follow-on protocols
- the feedback mformation is sent back to the client device 110 by a 'send feedback mformation " procedure 333 A 'resent feedback information' procedure 335 then presents the feedback mformation to the insured and/or the caregiver
- the ' evaluate patient mformation ' process 320 completes through an " end " terminal 337
- the 'determme feedback mformation " procedure 331 can also provide the client dev ice 110 with additional data gathermg protocols that are dependent on the just-gathered mformation — to obtain additional mformation.
- the 'determine feedback mformation " procedure 331 checks to determme whether the just gathered information is out-to-limit. mdicates a trend, or should be forwarded to a medical professional
- Fig. 4 illustrates a respond to risk " process, mdicated by general reference character 400. that is configured to adjust the cost of the financial product between the components of the financial product for the msured The ' respond to risk " process
- the " respond to risk ' process 400 then continues to a risk change " decision procedure 403 that determines whether the current msured-agamst risk has sufficiently changed from the existing msured-agamst risk ret ⁇ ev ed from the database 121 If the msured-agamst risk has not sufficiently changed, the " responded to risk " process 400 completes through .an " end " terminal 405 Otherwise, the " respond to risk " process 400 contmues to an " allocate benefits ' procedure 407 that reallocates the cost to the insured between the components of the financial product to correspond to the new msured-agamst risk Where the msured-agamst risk is reduced, the new allocation rewards the msured However, if the msured-agamst risk has mcreased.
- an " inform procedure 409 generates mformation that will be provided to the msured and/or the caregiver either usmg postal mail or as mformation provided to the insured by the " present feedback mformation " procedure 335
- This procedure also provides the new allocations to an accounting database and/or the payout system for the financial product
- the 'respond to risk' process 400 completes through the " end " terminal 405
- the 'allocate benefits " procedure 407 determmes a cost for the long-term car component and allocates a first payment to that component of the financial product
- the "allocate benefits " procedure 407 then allocates a second payment to the life insurance component of the financial product, to any annuity, or to another benefit for the msured (such as a refund)
- the second payment is a function of the first payment T his payment allocation is structured to provide an mcentive to the msured to conform to the currently suggested medical regimen
- Fig. 5 illustrates a "determme feedback information ' process, mdicated by general reference character 500. used to assemble the feedback information
- the "determine feedback information " process 500 is invoked by the "determme feedback mformation " procedure 331 and initiates at a " start " termmal 501
- a ' correlate regimen with risk factors procedure 503 uses the risk factors determined by the ' reassess risk ' procedure 327 to select one or m ore medical regimens that can be provided to the insured
- An " evaluate regimen history procedure 505 uses the historv of medical regimens suggested to the msured and stored on the database 121 to determme the preferred selection of medical regimens
- a modifv regimen procedure 507 modifies the existing medical regimen if the existmg medical regimen is different from the preferred medical regimen
- the modify regimen procedure 507 may change the data collection protocol used bv the client device 110
- These procedures 503, 505, and 507 are all dynamic m that they use historical mformation collected from the m
- the "correlate regimen with risk factors" procedure 503 evaluates the risk factors, the msured ' s progression and the information gathered from the insured to identify medical regimens best suited to gather additional information from the msured or to help the insured to reduce the msured-agamst risk
- One embodiment of the mv ention uses Bavesian statistical techniques to perform this correlation
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU61589/99A AU6158999A (en) | 1998-09-23 | 1999-09-22 | Reducing risk using behavioral and financial rewards |
EP99948399A EP1032903A1 (en) | 1998-09-23 | 1999-09-22 | Reducing risk using behavioral and financial rewards |
CA002310648A CA2310648A1 (en) | 1998-09-23 | 1999-09-22 | Reducing risk using behavioral and financial rewards |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15905898A | 1998-09-23 | 1998-09-23 | |
US09/159,058 | 1998-09-23 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2000017800A1 WO2000017800A1 (en) | 2000-03-30 |
WO2000017800A8 WO2000017800A8 (en) | 2000-08-03 |
WO2000017800A9 true WO2000017800A9 (en) | 2000-10-05 |
Family
ID=22570907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/022020 WO2000017800A1 (en) | 1998-09-23 | 1999-09-22 | Reducing risk using behavioral and financial rewards |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1032903A1 (en) |
AU (1) | AU6158999A (en) |
CA (1) | CA2310648A1 (en) |
WO (1) | WO2000017800A1 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8690796B2 (en) | 2002-04-19 | 2014-04-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8845550B2 (en) | 2001-06-12 | 2014-09-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8905945B2 (en) | 2002-04-19 | 2014-12-09 | Dominique M. Freeman | Method and apparatus for penetrating tissue |
US8945910B2 (en) | 2003-09-29 | 2015-02-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9144401B2 (en) | 2003-06-11 | 2015-09-29 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8140358B1 (en) | 1996-01-29 | 2012-03-20 | Progressive Casualty Insurance Company | Vehicle monitoring system |
US8090598B2 (en) | 1996-01-29 | 2012-01-03 | Progressive Casualty Insurance Company | Monitoring system for determining and communicating a cost of insurance |
GB2363874B (en) * | 1999-11-06 | 2004-08-04 | Dennis Sunga Fernandez | Bioinformatic transaction scheme |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US7708701B2 (en) | 2002-04-19 | 2010-05-04 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
EP1765194A4 (en) | 2004-06-03 | 2010-09-29 | Pelikan Technologies Inc | Method and apparatus for a fluid sampling device |
US9916625B2 (en) | 2012-02-02 | 2018-03-13 | Progressive Casualty Insurance Company | Mobile insurance platform system |
US11080790B2 (en) | 2009-09-24 | 2021-08-03 | Guidewire Software, Inc. | Method and apparatus for managing revisions and tracking of insurance policy elements |
US9053516B2 (en) | 2013-07-15 | 2015-06-09 | Jeffrey Stempora | Risk assessment using portable devices |
US9870448B1 (en) * | 2014-11-10 | 2018-01-16 | State Farm Mutual Automobile Insurance Company | Systems and methods for analyzing insurance claims associated with long-term care insurance |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2231420A (en) * | 1989-04-04 | 1990-11-14 | Agency Management Services Inc | Insurance rating |
ES2108613B1 (en) * | 1994-09-01 | 1998-08-01 | Perez Salvador Minguijon | SYSTEM TO ASSESS RISK IN AUTOMOBILE VEHICLES. |
US5752236A (en) * | 1994-09-02 | 1998-05-12 | Sexton; Frank M. | Life insurance method, and system |
-
1999
- 1999-09-22 WO PCT/US1999/022020 patent/WO2000017800A1/en not_active Application Discontinuation
- 1999-09-22 AU AU61589/99A patent/AU6158999A/en not_active Abandoned
- 1999-09-22 CA CA002310648A patent/CA2310648A1/en not_active Abandoned
- 1999-09-22 EP EP99948399A patent/EP1032903A1/en not_active Withdrawn
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8845550B2 (en) | 2001-06-12 | 2014-09-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8690796B2 (en) | 2002-04-19 | 2014-04-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8905945B2 (en) | 2002-04-19 | 2014-12-09 | Dominique M. Freeman | Method and apparatus for penetrating tissue |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9144401B2 (en) | 2003-06-11 | 2015-09-29 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US8945910B2 (en) | 2003-09-29 | 2015-02-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
Also Published As
Publication number | Publication date |
---|---|
AU6158999A (en) | 2000-04-10 |
EP1032903A1 (en) | 2000-09-06 |
WO2000017800A1 (en) | 2000-03-30 |
WO2000017800A8 (en) | 2000-08-03 |
CA2310648A1 (en) | 2000-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000017800A9 (en) | Reducing risk using behavioral and financial rewards | |
Fortin et al. | Identifying patient preferences for communicating risk estimates: a descriptive pilot study | |
US8595023B2 (en) | Weight control system with meal plan and journal | |
Wolfson | Social Proprioception: 1 Measurement, Data, and Information from a Population Health Perspective | |
KR102200422B1 (en) | Personal custom healthcare system that utilizes personal health and medical data | |
US20030233260A1 (en) | Computerized system and method of performing insurability analysis | |
US20050065813A1 (en) | Online medical evaluation system | |
US20080306763A1 (en) | System and Method for Modifying Risk Factors by a Healthcare Individual at a Remote Location | |
US11120906B2 (en) | System for improving patient medical treatment plan compliance | |
US20080010086A1 (en) | Health financial needs calculator | |
JP2001515233A (en) | A system for monitoring and returning the ability of medical behavior modification to follow a program | |
WO2000017799A1 (en) | Dynamic modeling and scoring risk assessment | |
Wittenberg et al. | Measuring the preferences of homeless women for cervical cancer screening interventions: development of a best–worst scaling survey | |
Krauss | Use of health care services, 1996 | |
US20090198516A1 (en) | System and method of managing diabetes employing an interactive website | |
WO2016077727A1 (en) | Method and apparatus for performing health risk assessment | |
Kim et al. | Development of implementation strategies for u-health services based on the healthcare professionals' experiences | |
KR20030070871A (en) | A health control process based on internet | |
Dant et al. | Private physicians or walk-in clinics: Do the patients differ? | |
US20030018240A1 (en) | Chronic heart failure patient identification system | |
Balacki | Assessing mental health needs in the rural community: a critique of assessment approaches | |
Nolinske | Survey research and measurement error | |
Cheyney | Understanding recent home-birth research: an interview with Drs. Melissa Cheyney and Jonathan Snowden | |
KR102594948B1 (en) | Metabolic syndrome ai primary doctor system | |
Menschner et al. | Empirically grounded design of a nutrition tracking system for patients with eating disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase in: |
Ref country code: CA Ref document number: 2310648 Kind code of ref document: A Format of ref document f/p: F Ref document number: 2310648 Country of ref document: CA |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1999948399 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 61589/99 Country of ref document: AU |
|
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: PAT. BUL. 13/2000 UNDER (81) DELETE "US" |
|
WWP | Wipo information: published in national office |
Ref document number: 1999948399 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1-23, DESCRIPTION, REPLACED BY NEW PAGES 1-13; PAGES 24-29, CLAIMS, REPLACED BY NEW PAGES 14-16; PAGES 1/9-9/9, DRAWINGS, REPLACED BY NEW PAGES 1/7-7/7; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999948399 Country of ref document: EP |